rectal cancer	is a	malignancy of rectum
anal cancer	is a	malignancy of anal canal
rectal cancer	metastasizes to	liver
rectal cancer	metastasizes to	lung
rectal cancer	metastasizes to	bone
rectal cancer	presents with	rectal bleeding
rectal cancer	presents with	change in bowel habit
rectal cancer	presents with	tenesmus
rectal cancer	presents with	abdominal pain
rectal cancer	causes	obstruction
age	is risk factor for	rectal cancer
family history	is risk factor for	rectal cancer
IBD	is risk factor for	rectal cancer
Lynch syndrome	is risk factor for	rectal cancer
FAP	is risk factor for	rectal cancer
smoking	is risk factor for	rectal cancer
obesity	is risk factor for	rectal cancer
low fiber diet	is risk factor for	rectal cancer
red meat intake	is risk factor for	rectal cancer
alcohol consumption	is risk factor for	rectal cancer
HPV infection	is risk factor for	anal cancer
immunosuppression	is risk factor for	anal cancer
HPV infection	is etiologic agent for	anal cancer
rectal cancer	treated with	surgery
anal cancer	treated with	chemoradiation
rectal cancer	treated with	neoadjuvant therapy
neoadjuvant therapy	includes	chemoradiation
surgery	may involve	colostomy
low anterior resection	is a	surgical procedure
abdominoperineal resection	is a	surgical procedure
total mesorectal excision	is a	surgical procedure
preoperative radiotherapy	reduces	local recurrence
neoadjuvant chemoradiation	reduces	local recurrence
radiation therapy	reduces	local recurrence
adjuvant chemotherapy	improves	disease-free survival
FOLFOX	is a regimen for	rectal cancer
CAPOX	is a regimen for	rectal cancer
preoperative chemoradiation	enables	sphincter preservation
sphincter-sparing surgery	preserves	continence
colostomy	created during	abdominoperineal resection
colostomy	affects	quality of life
stoma	requires	stoma care
sphincter preservation	aims for	continence
liver metastasis	indicates	advanced disease
liver metastasis	reduces	survival
KRAS mutation	predicts	resistance to anti-EGFR therapy
NRAS mutation	predicts	resistance to anti-EGFR therapy
BRAF mutation	associated with	poor prognosis
MSI-high status	predicts	favorable prognosis
MSI-high status	predicts	response to immunotherapy
CEA	is tumor marker for	rectal cancer
carcinoembryonic antigen	is elevated in	rectal cancer
biopsy	confirms	rectal cancer
colonoscopy	detects	rectal cancer
MRI pelvis	stages	rectal cancer
CT chest abdomen pelvis	staging tool for	rectal cancer
PET scan	detects	metastasis
TNM staging	classifies	rectal cancer
stage II	prognosis indicator for	rectal cancer
stage III	prognosis indicator for	rectal cancer
positive lymph nodes	indicate	higher recurrence
negative margins	predict	lower recurrence
pathology	confirms	adenocarcinoma
rectal cancer	histology	adenocarcinoma
adenocarcinoma	is histology type for	rectal cancer
surgical margins	influence	recurrence risk
lymph node status	influences	prognosis
tumor size	correlates with	stage
neoadjuvant therapy	improves	tumor downstaging
pathology	reports	tumor regression grade
tumor regression grade	correlates with	prognosis
staging	determines	surgical plan
staging	guides	adjuvant therapy decision
neoadjuvant therapy	increases	sphincter preservation rate
adjuvant therapy	reduces	recurrence
palliative care	addresses	advanced disease symptoms
stent	palliates	obstruction from rectal cancer
stent placement	relieves	obstruction symptoms
chemoradiation	can cause	bowel dysfunction
anastomotic leak	increases	morbidity
colorectal cancer recurrence	risk after	surgery
bevacizumab	added to	chemotherapy
cetuximab	added to	chemotherapy
RAS wild-type status	predicts	response to anti-EGFR therapy
HPV vaccination	reduces risk of	anal cancer
immunotherapy	effective in	MSI-high rectal cancer
neoadjuvant chemoradiation	achieves	tumor downstaging
pathology	yields	tumor regression grade
staging	uses	TNM system
rectal cancer incidence	increases with	age
rectal cancer survival	varies by	stage
occult blood test	detects	blood in stool
colorectal cancer screening	reduces	mortality
polypectomy	prevents	progression to rectal cancer
anesthesia	used during	rectal cancer surgery
postoperative infection	increases	length of stay
stoma care	improves	patient education
multidisciplinary team	coordinates	rectal cancer care
nutrition	supports	cancer treatment tolerance
physical activity	improves	quality of life in rectal cancer
radiation-induced proctitis	causes	bowel symptoms
postoperative ileus	prolongs	hospitalization
oncology	coordinates	systemic therapy for rectal cancer
gastrointestinal toxicity	limits	therapy dose
neutropenia	risks	chemotherapy
